These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 10740989)
1. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. Kapur S; Seeman P J Psychiatry Neurosci; 2000 Mar; 25(2):161-6. PubMed ID: 10740989 [TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
3. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors. Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. Lidow MS; Goldman-Rakic PS J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417 [TBL] [Abstract][Full Text] [Related]
5. The fast-off hypothesis revisited: A functional kinetic study of antipsychotic antagonism of the dopamine D2 receptor. Sahlholm K; Zeberg H; Nilsson J; Ögren SO; Fuxe K; Århem P Eur Neuropsychopharmacol; 2016 Mar; 26(3):467-76. PubMed ID: 26811292 [TBL] [Abstract][Full Text] [Related]
6. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography. Seeman P; Tallerico T; Ko F Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639 [TBL] [Abstract][Full Text] [Related]
7. Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer. Barth VN; Chernet E; Martin LJ; Need AB; Rash KS; Morin M; Phebus LA Life Sci; 2006 May; 78(26):3007-12. PubMed ID: 16434058 [TBL] [Abstract][Full Text] [Related]
8. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Malmberg A; Jackson DM; Eriksson A; Mohell N Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194 [TBL] [Abstract][Full Text] [Related]
9. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828 [TBL] [Abstract][Full Text] [Related]
10. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Seeman P; Corbett R; Van Tol HH Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795 [TBL] [Abstract][Full Text] [Related]
11. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action. Maheux J; Ethier I; Rouillard C; Lévesque D J Pharmacol Exp Ther; 2005 Apr; 313(1):460-73. PubMed ID: 15615863 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic receptor-blocking concentrations of neuroleptics. Seeman P Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():5-13. PubMed ID: 8866760 [TBL] [Abstract][Full Text] [Related]
13. Expression of noradrenergic alpha1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs. Ma J; Ye N; Cohen BM Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):647-57. PubMed ID: 16487641 [TBL] [Abstract][Full Text] [Related]
14. The importance of serotonin-dopamine interactions in the action of clozapine. Meltzer HY Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment. Tarazi FI; Florijn WJ; Creese I Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067 [TBL] [Abstract][Full Text] [Related]
16. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex. Assié MB; Consul-Denjean N; Koek W; Newman-Tancredi A Pharmacology; 2005 Oct; 75(2):63-8. PubMed ID: 16020947 [TBL] [Abstract][Full Text] [Related]
17. Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor. Hjerde E; Dahl SG; Sylte I Eur J Med Chem; 2005 Feb; 40(2):185-94. PubMed ID: 15694653 [TBL] [Abstract][Full Text] [Related]
18. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle. Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077 [TBL] [Abstract][Full Text] [Related]
19. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor. Rauser L; Savage JE; Meltzer HY; Roth BL J Pharmacol Exp Ther; 2001 Oct; 299(1):83-9. PubMed ID: 11561066 [TBL] [Abstract][Full Text] [Related]
20. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Xu R; Hranilovic D; Fetsko LA; Bucan M; Wang Y Mol Psychiatry; 2002; 7(10):1075-82. PubMed ID: 12476322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]